Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer

Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer is a phase 2, randomised interventional study registered as NCT05220800 by Zealand University Hospital, with a registry enrolment figure of 134 participants, started 2022-03-01 and due to reach its primary completion in 2024-03-01. Interventions recorded: Iron(III)isomaltoside; Placebo. Conditions listed: Iron-deficiency; Colorectal Cancer. Primary outcome: Change in oxygen uptake at the anaerobic threshold; Change in neutrophile to lymphocyte ratio (NLR); Changes in T-cell function - mRNA expression analysis. Colorectal eligibility wording from the registry: "* Planned for curative intended elective colon or rectum cancer surgery". Sites: Denmark. No results are recorded here; the registry entry is the source.